- Home
- SABR vs LAB Comparison
SABR vs LAB Comparison
Compare SABR & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SABR | LAB |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 489.7M | 488.4M |
| IPO Year | 2014 | 2008 |
Fundamental Metrics
Financial Performance| Metric | SABR | LAB |
|---|---|---|
| Price | $0.81 | $1.14 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | ★ $4.15 | $1.35 |
| AVG Volume (30 Days) | ★ 10.8M | 1.2M |
| Earning Date | 05-21-2026 | 04-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 283.56 | 44.68 |
| EPS | ★ 1.34 | N/A |
| Revenue | ★ $3,866,956,000.00 | $101,937,000.00 |
| Revenue This Year | $6.79 | N/A |
| Revenue Next Year | $3.14 | N/A |
| P/E Ratio | $0.67 | ★ N/A |
| Revenue Growth | ★ 7.46 | N/A |
| 52 Week Low | $0.89 | $0.92 |
| 52 Week High | $4.38 | $1.72 |
Technical Indicators
Market Signals| Indicator | SABR | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 33.71 | 31.80 |
| Support Level | N/A | $1.09 |
| Resistance Level | $1.39 | $1.13 |
| Average True Range (ATR) | 0.12 | 0.06 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 2.00 | 7.14 |
Price Performance
Historical ComparisonAbout SABR Sabre Corporation
Sabre holds the number-two air booking volume share in the global distribution system industry. The travel solutions segment represented 91% of total 2024 revenue, split between distribution (79% of segment sales) and airline IT solutions (21%) revenue. The company sold its growing hotel IT solutions division (9% of revenue) to TPG in 2025 for $960 million in net proceeds. Transaction fees, which are mostly tied to volume and not price, account for the bulk of sales and profits.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.